Patient Information Leaflet: Information for the Patient
Fenofibrate Teva 160 mg Film-Coated Tablets
Read this leaflet carefully before you start taking this medicine because it contains important information for you.
1. What is Fenofibrate Teva and what it is used for
2. What you need to know before taking Fenofibrate Teva
3. How to take Fenofibrate Teva
4. Possible side effects
5. Storage of Fenofibrate Teva
6. Contents of the pack and additional information
Fenofibrato Teva belongs to a group of medications commonly known as fibrates. These medications are used to decrease the level of fats (lipids) in the blood, for example, fats known as triglycerides.
Fenofibrato Teva is used in conjunction with a low-fat diet and other non-medication treatments such as exercise and weight loss, to decrease blood fat levels.
Fenofibrato Teva may be used in conjunction with other medications (statins) in certain circumstances when a statin alone does not control blood fat levels.
Do not take Fenofibrato Teva
Do not take Fenofibrato Teva if any of the above circumstances apply to you. If you are unsure, consult your doctor or pharmacist before taking Fenofibrato Teva.
Warnings and precautions
Consult your doctor or pharmacist before taking Fenofibrato Teva:
If any of the above circumstances apply to you (or you are unsure), consult your doctor or pharmacist before taking Fenofibrato Teva.
Fenofibrato Teva and muscle effects
Stop taking Fenofibrato Teva and see your doctor immediately if you experience:
This is because this medication can cause muscle problems that can be serious. These problems occur in rare cases but include inflammation and muscle destruction. This can cause kidney damage or even death.
Your doctor may do a blood test to check the condition of your muscles before and after starting treatment. The risk of muscle problem is higher in some patients. In particular, consult your doctor if:
If any of the above circumstances apply to you (or you are unsure), consult your doctor or pharmacist before taking Fenofibrato Teva.
Your doctor may ask you to have regular blood tests to monitor the function of your liver and kidneys.
Sometimes pancreatitis occurs in some patients taking fenofibrate (inflammation of the pancreas that causes abdominal pain): see the section above “Do not take Fenofibrato Teva” and the section 4 below.
Taking Fenofibrato Teva and other medications
Inform your doctor or pharmacist if you are taking, have taken recently, or might need to take any other medication.
In particular, inform your doctor or pharmacist if you are taking any of the following medications:
If any of the above circumstances apply to you (or you are unsure), consult your doctor or pharmacist before taking Fenofibrato Teva.
Pregnancy and breastfeeding
Inform your doctor if you are pregnant, think you might be pregnant, or plan to become pregnant. This is because it is unknown how Fenofibrato Teva may affect the newborn. Only use Fenofibrato Teva if your doctor advises you to.
Do not use Fenofibrato Teva if you are breastfeeding or plan to breastfeed. This is because it is unknown if Fenofibrato Teva passes into breast milk.
Driving and using machines
This medication does not affect your ability to drive or use tools or machines.
Fenofibrato Teva contains soy lecithin
Do not use in case of allergy to peanuts, arachidic oil, or soy (see “do not take Fenofibrato Teva”)
Fenofibrato Teva contains lactose
If your doctor has told you that you have an intolerance to certain sugars, consult with them before taking this medication.
Fenofibrato Teva contains sodium
This medication contains less than 23 mg of sodium (1 mmol) per tablet; this is, essentially “sodium-free”
Follow exactly the administration instructions for this medication as indicated by your doctor or pharmacist. Consult your doctor or pharmacist if you have any doubts.
Your doctor will determine the appropriate dose for you, depending on your condition, current treatment, and personal risk factors.
Medication Taking
Take the tablet with food, as it does not work as well if your stomach is empty.
Remember that in addition to taking Fenofibrate Teva, it is also important that:
How Much to Take
The recommended dose is one tablet per day, including elderly patients.
If you are currently taking capsules of 200 mg of fenofibrate, you can switch to a Fenofibrate Teva 160 mg tablet. You will still receive the same amount of medication.
If You Have Kidney Problems
If you have kidney problems, your doctor may recommend a lower dose. Consult your doctor or pharmacist about this.
Use in Children and Adolescents
Fenofibrate Teva is not recommended for use in children and adolescents under 18 years old.
If You Take Too Much Fenofibrate Teva
If you accidentally take too many tablets or think a child has swallowed one, contact your nearest hospital or inform your doctor immediately.
In case of overdose or accidental ingestion, consult your doctor immediately or call the Toxicology Information Service, phone 915 620 420, indicating the medication and the amount ingested.
If You Forget to Take Fenofibrate Teva
If you forget to take a dose, take the next dose with your next meal.
Then take the next dose at the usual time.
Do not take a double dose to make up for missed doses.
If You Stop Taking Fenofibrate Teva
Do not stop taking Fenofibrate Teva unless your doctor tells you to or if the tablets make you feel unwell. This is because it requires long-term treatment. If your doctor stops the medication, do not keep the remaining tablets unless your doctor tells you to.
If you have any other questions about the use of this medication, ask your doctor or pharmacist
.
Like all medications, this one may cause side effects, although not everyone will experience them.
Stop taking Fenofibrate Teva and consult your doctor immediately if you experience any of the following severe side effects – you may need urgent medical treatment:
Rare: may affect up to 1 in 100 people)
Rare: may affect up to 1 in 1,000 people
Unknown: the frequency cannot be estimated from available data
Long-term respiratory problems
Stop taking Fenofibrate Teva and consult a doctor immediately if you notice any of the above side effects.
Other side effects include:
Consult your doctor or pharmacist if you experience any of the following side effects:
Frequent: may affect 1 in 10 patients:
Rare: may affect up to 1 in 100 people
Rare: may affect up to 1 in 1,000 people
Unknown: the frequency cannot be estimated from available data
Consult your doctor or pharmacist if you experience any side effects mentioned.
Reporting side effects:
If you experience any type of side effect, consult your doctor or pharmacist, even if it is a possible side effect that does not appear in this prospectus. You can also report them directly through the Spanish System of Pharmacovigilance of Medicines for Human Use: https://www.notificaram.es. By reporting side effects, you can contribute to providing more information on the safety of this medication.
Fenofibrate Teva Composition
- The active ingredient is fenofibrate. Each film-coated tablet contains 160 mg of fenofibrate.
- The other components are: microcrystalline cellulose, povidone K-30, povidone K-25,
croscarmellose sodium, crospovidone, sodium alginate (type A), sodium lauryl sulfate
lactose monohydrate, anhydrous colloidal silica, sodium stearate fumarate, partially
hydrolyzed polyvinyl alcohol, titanium dioxide (E171), talc, soy lecithin, and xanthan gum.
Appearance of Fenofibrate Teva and contents of the packaging
- White or almost white, oval-shaped, film-coated tablets, marked with “93” on one face and “7331” on the other
- Fenofibrate Teva 160 mg is available in packaging of 1, 10, 14, 15, 28, 30, 50, 56, 60, 84, 90, or 100 film-coated tablets.
Not all packaging sizes may be marketed.
Marketing Authorization Holder
Teva Pharma, S.L.U.
C/Anabel Segura 11, Edificio Albatros B, 1st Floor
28108 Alcobendas, Madrid
Manufacturers
Pharmachemie B.V.
Swensweg 5, 2031 GA Haarlem
Holland
Teva Operations Poland Sp. z.o.o.
ul. Mogilska 80, 31-546 Krakow
Poland
Teva Czech Industries s.r.o.
Ostravska 29, c.p. 305, Building No 80 Small OSD and building No 881 NOSD,
747 70 Opava-Komarov
Republic of Czech
Last review date of this leaflet:January 2022
Detailed and updated information on this medicine is available on the website of the Spanish Agency for Medicines and Medical Devices (AEMPS)http://www.aemps.gob.es/
You can access detailed and updated information on this medicine by scanning the QR code included in the carton with your smartphone. You can also access this information at the following internet address: https://cima.aemps.es/cima/dochtml/p/72706/P_72706.html
Есть вопросы по этому лекарству или вашим симптомам? Свяжитесь с лицензированным врачом для получения помощи и персонализированного ухода.